KK
HAE icon

KLP Kapitalforvaltning’s Haemonetics HAE Stock Holding History

KLP Kapitalforvaltning’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$900K Sell
12,000
-12,600
-51% -$809K ﹤0.01% 1186
2026
Q1 		$1.39M Buy
24,600
+14,300
+139% +$931K 0.01% 869
2025
Q4 		$826K Buy
10,300
+200
+2% +$13.4K ﹤0.01% 1133
2025
Q3 		$492K Hold
10,100
– – ﹤0.01% 1402
2025
Q2 		$754K Hold
10,100
– – ﹤0.01% 1137
2025
Q1 		$642K Hold
10,100
– – ﹤0.01% 1158
2024
Q4 		$789K Buy
+10,100
New +$811K ﹤0.01% 1101

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KLP Kapitalforvaltning's HAE Position: Q2 2026 in Review

KLP Kapitalforvaltning reduced its Haemonetics (HAE) stake by 51% in Q2 2026, selling an estimated $809K and leaving 12,000 shares worth $900K. The position accounts for ﹤0.01% of the portfolio, ranked #1186.

KLP Kapitalforvaltning first reported a position in HAE in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.39M in Q1 2026. 330 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • KLP Kapitalforvaltning held 12,000 shares of Haemonetics worth $900K as of Q2 2026.
  • KLP Kapitalforvaltning sold 12,600 Haemonetics shares in Q2 2026, an estimated $809K.
  • Haemonetics made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1186 holding.
  • KLP Kapitalforvaltning first reported a position in Haemonetics in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's Haemonetics position peaked at $1.39M in Q1 2026.
  • 330 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.